VivoSim Labs, INC. Cash Flow Statement
VIVS|13 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
VivoSim Labs, INC. used $15M in operating cash flow and negative free cash flow of $15M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.72 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$14.7M | -$17.3M | -$11.4M | -$16.8M | -$18.7M | -$26.6M | -$34.8M | -$38.6M | -$30.1M | -$25.8M | -$43.6M | -$98.0K | -$98.0K |
| Depreciation & Amortization | $280.0K | $293.0K | $142.0K | $41.0K | $1.1M | $980.0K | $1.3M | $815.0K | $472.0K | $387.0K | $195.0K | $68.0K | $68.0K |
| Operating Cash Flow | -$14.7M | -$12.4M | -$8.5M | -$13.3M | -$14.9M | -$20.4M | -$28.9M | -$29.4M | -$19.6M | -$15.6M | -$9.7M | -$15.6M | -$1.9M |
| Capital Expenditures | $42.0K | $396.0K | $409.0K | $405.0K | $0 | $79.0K | $226.0K | $2.1M | $1.5M | $277.0K | $357.0K | $46.0K | $46.0K |
| Free Cash Flow | -$14.7M | -$12.8M | -$8.9M | -$13.7M | -$14.9M | -$20.5M | -$29.1M | -$31.5M | -$21.1M | -$15.8M | -$10.1M | -$15.6M | -$2.0M |
| Share Buybacks | - | - | - | $1.0K | $0 | - | - | - | - | - | - | - | - |
| FCF Margin | -13481.6% | -3460.5% | -590.8% | - | -677.7% | -661.7% | -631.8% | -2122.9% | -3698.4% | -4178.9% | -839.6% | -1610.6% | -202.3% |